ΔNp73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation In Vivo

REFERENCES

• Askew, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive cMyc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915–1922.
   PubMed Web of Science ®Google Scholar
• Blyth, K., A. Terry, M. O'Hara, E. W. Baxter, M. Campbell, M. Stewart, L. A. Donehower, D. E. Onions, J. C. Neil, and E. R. Cameron. 1995. Synergy between a human cMyc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10: 1717–1723.
   PubMed Web of Science ®Google Scholar
• Casciano, I., K. Mazzocco, L. Boni, G. Pagnan, B. Banelli, G. Allemanni, M. Ponzoni, G. P. Tonini, and M. Romani. 2002. Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ. 3: 246–251.
   Google Scholar
• DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 14: 7245–7250.
   Google Scholar
• de Stanchina, E., M. E. McCurrach, F. Zindy, S. Y. Shieh, G. Ferbeyre, A. V. Samuelson, C. Prives, M. F. Roussel, C. J. Sherr, and S. W. Lowe. 1998. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev. 15: 2434–2442.
   Google Scholar
• Dietz, S., K. Rother, C. Bamberger, H. Schmale, J. Mossner, and K. Engeland. 2002. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett. 1 -3: 93–99.
   Google Scholar
• Douc-Rasy, S., M. Barrois, M. Echeynne, M. Kaghad, E. Blanc, G. Raguenez, D. Goldschneider, M. J. Terrier-Lacombe, O. Hartmann, U. Moll, D. Caput, and J. Benard. 2002. ΔN-p73α accumulates in human neuroblastic tumors. Am. J. Pathol. 2: 631–639.
   Google Scholar
• Elson, A., C. Deng, J. Campos-Torres, L. A. Donehower, and P. Leder. 1995. The MMTV/cMyc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11: 181–190.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by cMyc protein. Cell 69: 119–128.
   PubMed Web of Science ®Google Scholar
• Grob, T. J., U. Novak, C. Maisse, D. Barcaroli, A. U. Luthi, F. Pirnia, B. Hugli, H. U. Graber, V. De Laurenzi, M. F. Fey, G. Melino, and A. Tobler. 2001. Human ΔNp73 regulates a dominant-negative feedback loop for TAp73 and p53. Cell Death Differ. 8: 1213–1223.
   PubMed Web of Science ®Google Scholar
• Irwin, M., M. C. Marin, A. C. Phillips, R. S. Seelan, D. I. Smith, W. Liu, E. R. Flores, K. Y. Tsai, T. Jacks, K. H. Vousden, and W. G. Kaelin. 2000. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407: 645–648.
   PubMed Web of Science ®Google Scholar
• Ishimoto, O., K. Kawahara, K. Enjo, M. Obinata, T. Nukiwa, and S. Ikawa. 2002. Possible oncogenic potential of ΔNp73: a newly identified isoform of human p73. Cancer Res. 62:636–641.
   PubMed Web of Science ®Google Scholar
• Jackman, J., and P. M. O'Connor. 1998. Cell cycle analysis, p. 8314. In J. S. Bonifacino (ed.), Current protocols in cell biology, vol. I. John Wiley & Sons, Inc., New York, N.Y.
   Google Scholar
• Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1–7.
   PubMed Web of Science ®Google Scholar
• Jochum, W., E. Passegue, and E. F. Wagner. 2001. AP-1 in mouse development and tumorigenesis. Oncogene 19: 2401–2412.
   Google Scholar
• Jost, C. A., M. C. Marin, and W. G. Kaelin, Jr. 1997. p73 is a simian p53-related protein that can induce apoptosis. Nature 389: 191–194.
   PubMed Web of Science ®Google Scholar
• Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J. C. Biscan, A. Valent, A. Minty, P. Chalon, J. M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809–819.
   PubMed Web of Science ®Google Scholar
• Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 5: 649–659.
   Google Scholar
• Krimpenfort, P., K. C. Quon, W. J. Mooi, A. Loonstra, and A. Berns. 2001. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 6851: 83–86.
   Google Scholar
• Kohl, N. E., and H. E. Ruley. 1987. Role of cMyc in the transformation of REF52 cells by viral and cellular oncogenes. Oncogene 2: 41–48.
   PubMed Web of Science ®Google Scholar
• Kovalev, S., N. D. Marchenko, S. Swendeman, M. LaQuaglia, and U. M. Moll. 1998. Expression level, allelic origin and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ. 9: 897–903.
   PubMedGoogle Scholar
• Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 5927: 596–602.
   Google Scholar
• Lissy, N. A., P. K. Davis, M. Irwin, W. G. Kaelin, and S. F. Dowdy. 2000. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407: 642–645.
   PubMed Web of Science ®Google Scholar
• McCormick, F., and A. Wittinghofer. 1996. Interactions between Ras proteins and their effectors. Curr. Opin. Biotechnol. 4: 449–456.
   Google Scholar
• Moll, U. M., S. Erster, and A. Zaika. 2001. p53, p63, and p73: solos, alliances, and feuds among family members. Biochim. Biophys. Acta 1552: 47–59.
   PubMedGoogle Scholar
• Nakagawa, T., M. Takahashi, T. Ozaki, K. Watanabe, S. Todo, H. Mizuguchi, T. Hayakawa, and A. Nakagawara. 2002. Autoinhibitory regulation of p73 by ΔNp73 to modulate cell survival and death through a p73-specific target element within the ΔNp73 promoter. Mol. Cell. Biol. 22: 2575–2585.
   PubMedGoogle Scholar
• Palmero, I., C. Pantoja, and M. Serrano. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 6698: 125–126.
   Google Scholar
• Peeper, D. S., A. Shvarts, T. Brummelkamp, S. Douma, E. Y. Koh, G. Q. Daley, and R. Bernards. 2002. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol. 2: 148–153.
   Google Scholar
• Petrenko, O., A. Beavis, M. Klaine, R. Kittappa, I. Godin, and I. R. Lemischka. 1999. The molecular characterization of the fetal stem cell marker AA4. Immunity 10: 691–700.
   PubMedGoogle Scholar
• Pozniak, C. D., S. Radinovic, A. Yang, F. McKeon, D. R. Kaplan, and F. D. Miller. 2000. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289: 304–306.
   PubMed Web of Science ®Google Scholar
• Pozniak, C. D., F. Barnabe-Heider, V. V. Rymar, A. F. Lee, A. F. Sadikot, and F. D. Miller. 2002. p73 is required for survival and maintenance of CNS neurons. J. Neurosci. 22: 9800–9809.
   PubMed Web of Science ®Google Scholar
• Ruley, H. E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 5927: 602–606.
   Google Scholar
• Samuelson, A. V., and S. W. Lowe. 1997. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl. Acad. Sci. USA 22: 12094–12099.
   Google Scholar
• Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 5: 593–602.
   Google Scholar
• Sharpless, N. E., N. Bardeesy, K. H. Lee, D. Carrasco, D. H. Castrillon, A. J. Aguirre, E. A. Wu, J. W. Horner, and R. A DePinho. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 6851: 86–91.
   Google Scholar
• Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 19: 2984–2991.
   Google Scholar
• Stiewe, T., S. Zimmermann, A. Frilling, H. Esche, and B. M. Putzer. 2002. Transactivation-deficient ΔTA-p73 acts as an oncogene. Cancer Res. 13: 3598–3602.
   Google Scholar
• Stiewe, T., J. Stanelle, C. C. Theseling, B. Pollmeier, M. Beitzinger, and B. M. Putzer. 2003. Inactivation of retinoblastoma (Rb) tumor suppressor by oncogenic isoforms of the p53 family member p73. J. Biol. Chem. 278: 14230–14236.
   PubMedGoogle Scholar
• Todaro, G. J, H. Green, and M. R. Swift. 1966. Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science 741: 1252–1254.
   Google Scholar
• Vogt, P. K. 2000. Fortuitous convergences: the beginnings of JUN. Nat. Rev. Cancer 6: 465–469.
   Google Scholar
• Weinberg, R. A. 1989. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 14: 3713–3721.
   Google Scholar
• Yang, A., N. Walker, R. Bronson, M. Kaghad, M. Oosterwegel, J. Bonnin, C. Vagner, H. Bonnet, P. Dikkes, A. Sharpe, F. McKeon, and D. Caput. 2000. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99–103.
   PubMed Web of Science ®Google Scholar
• Zaika, A. I., S. Kovalev, N. D. Marchenko, and U. M. Moll. 1999. Overexpression of the wild-type p73 gene in breast cancer tissues and cell lines. Cancer Res. 59: 3257–3263.
   PubMedGoogle Scholar
• Zaika, A., M. Irwin, C. Sansome, and U. M. Moll. 2001. Oncogenes induce and activate endogenous p73 protein. J. Biol. Chem. 276: 11310–11316.
   PubMed Web of Science ®Google Scholar
• Zaika, A. I., N. Slade, S. H. Erster, C. Sansome, T. W. Joseph, M. Pearl, E. Chalas, and U. M. Moll. 2002. ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is upregulated in human tumors. J. Exp. Med. 6: 765–780.
   Google Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 15: 2424–2433.
   Google Scholar
• Zhu, J., J. Jiang, W. Zhou, and X. Chen. 1998. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58: 5061–5065.
   PubMed Web of Science ®Google Scholar